Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAOA | P21397 | 1/20 | 0.40 |
| ▸ | MAPT | P10636 | 3/20 | 0.40 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.40 |
| ▸ | NUDT1 | P36639 | 3/20 | 0.37 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.37 |
| ▸ | ADORA2A | P29274 | 1/20 | 0.37 |
| ▸ | AKR1B1 | P15121 | 1/20 | 0.35 |
| ▸ | NR1I2 | O75469 | 1/20 | 0.35 |
| ▸ | EGFR | P00533 | 1/20 | 0.35 |
| ▸ | ADRA2A | P08913 | 1/20 | 0.35 |
| ▸ | ADORA3 | P0DMS8 | 1/20 | 0.35 |
| ▸ | TBXA2R | P21731 | 1/20 | 0.35 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.35 |
| ▸ | OPRD1 | P41143 | 1/20 | 0.35 |
| ▸ | PDE4D | Q08499 | 1/20 | 0.35 |
| ▸ | HPRT1 | P00492 | 1/20 | 0.35 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.35 |
| ▸ | CYP1A1 | P04798 | 1/20 | 0.35 |
| ▸ | CYP1B1 | Q16678 | 1/20 | 0.35 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL24731785 | 0.97 | MAOA (0.38) | MAOAMAPTL3MBTL1NUDT1KDM4E | |
| SCHEMBL23874806 | 0.90 | PDE7A (0.41) | MAOAMAPTL3MBTL1ADORA2AAKR1B1 | |
| SCHEMBL24702665 | 0.88 | MAPT (0.41) | MAOAMAPTL3MBTL1KDM4EADORA2A | |
| SCHEMBL20152506 | 0.82 | ADORA2A (0.55) | MAPTL3MBTL1NUDT1KDM4EADORA2A | |
| SCHEMBL23473691 | 0.79 | MAOA (0.37) | MAOAMAPTL3MBTL1ADORA2AAKR1B1 | |
| SCHEMBL19169192 | 0.79 | MAOA (0.46) | MAOAMAPTL3MBTL1NUDT1KDM4E | |
| SCHEMBL20152504 | 0.79 | ADORA2A (0.51) | MAPTNUDT1KDM4EADORA2AMEN1 | |
| SCHEMBL24183826 | 0.79 | L3MBTL1 (0.46) | MAOAMAPTL3MBTL1AKR1B1HPRT1 | |
| SCHEMBL24702663 | 0.78 | MAPT (0.43) | MAPTL3MBTL1NUDT1KDM4EADORA2A | |
| SCHEMBL10942572 | 0.77 | CYP1A1 (0.51) | MAOAMAPTL3MBTL1NUDT1KDM4E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20220399506-A1 | ELECTROLUMINESCENT DEVICE | Beijing Summer Sprout Technology Co., Ltd. (CN) | 2022-12-15 | — | — | US | disclosed |
| US-20220393116-A1 | ELECTROLUMINESCENT DEVICE | Beijing Summer Sprout Technology Co., Ltd. (CN) | 2022-12-08 | — | — | US | disclosed |
| US-20220251077-A1 | ORGANIC COMPOUND AND ORGANIC ELECTROLUMINESCENCE DEVICE USING THE SAME | LUMINESCENCE TECHNOLOGY CORP. (TW) | 2022-08-11 | — | — | US | disclosed |
| US-20210320263-A1 | ORGANIC ELECTROLUMINESCENT COMPOUND, A PLURALITY OF HOST MATERIALS, AND ORGANIC ELECTROLUMINESCENT DEVICE COMPRISING THE SAME | DUPONT SPECIALTY MATERIALS KOREA LTD. (KR) | 2021-10-14 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220251077-A1 | ORGANIC COMPOUND AND ORGANIC ELECTROLUMINESCENCE DEVICE USING THE SAME | SLCO4C1, SLCO2A1, SLCO2B1 | MAOA 395/4885MAPT 857/4885L3MBTL1 653/4885 |
| US-20220393116-A1 | ELECTROLUMINESCENT DEVICE | L1CAM, MCOLN2, MCOLN1 | MAOA 1282/4885MAPT 1062/4885L3MBTL1 28/4885 |
| US-20220399506-A1 | ELECTROLUMINESCENT DEVICE | L1CAM, LDHA, LDHB | MAOA 397/4885MAPT 3576/4885L3MBTL1 457/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.